The era of siteless clinical trials for drug development is here. Also known as virtual, remote and digital trials, siteless trials build on the “direct-to-patient” trend in clinical trial design.
Spencer Health Solutions, Inc. today introduced the spencer® full-circle patient engagement and medication adherence solution to clinical research during the eyeforpharma conference being held in Philadelphia.
Clinical trials are only as good as the data collected during the trial. Introduce even the slightest threat to your data’s integrity, and you’re giving yourself a challenge that could mean the costly difference between success and failure in any trial.
To understand the enormity of Spencer’s potential in the drug development realm, it’s important to understand one of the industry’s most common barriers.